Article Details

FDA Approves Takeda's Hyqvia for Maintenance of Chronic Inflammatory Demyelinating ...

Retrieved on: 2024-01-17 19:48:31

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves Takeda's Hyqvia for Maintenance of Chronic Inflammatory Demyelinating .... View article details on hiswai:

Excerpt

... immune system. The hyaluronidase in Hyqvia enables more immunoglobulin to be absorbed into the body. The drug derives its therapeutic effect from ...

Article found on: www.pharmexec.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo